24 Apr 2020 --- US-based Farlong Pharmaceutical will open up the sales of three Traditional Chinese Medicine (TCM) formulas to consumers, including Qing Fei Pai Du Tang (QPD), which has allegedly been recommended by the Chinese National Health Commission as a treatment for COVID-19. Farlong states that TCM doctors use the formula – which contains 21 herbal medicines – to dry lungs and support the organs. However, many companies have been warned in recent weeks for implying that their products can have an effect on COVID-19.
“In the past, patients had only taken these formulas under practitioners’ recommendations. With the coronavirus outbreak and a growing demand from consumers to be proactive in protecting their health, we are expanding availability directly to the public. I don’t think people will be discouraged from seeking standard medical care if they use these products, as they will help to relieve symptoms in a natural way,” Jing Struve, CEO and Executive Director of Farlong Pharmaceutical, tells NutritionInsight.
The US Food and Drug Administration (FDA) has been quick to clamp down on products with misleading claims that the products are safe or effective for the prevention and treatment of COVID-19. Meanwhile, the US state of Oregon recently introduced stricter measures to crack down on products featuring unsubstantiated claims about COVID-19.
Read the entire article here.